PRLog Free Press Release Distribution + Bookmark This Page
Home| Submit Free Press Release| News Archive| By Category| By Location| By Date| By Tag| Newsletter| 40,000 RSS Feeds 08:23 PM [GMT -05:00]
 

Filter

Category

Country

State / Province
Select Country First

City / Town
Select State First

http://www.jobs4dd.com/news.php?NEWS_ID=257

Matrix Group (Hyderabad, India) and ethica Clinical Research (Montreal, Canada) have formed a joint venture, ethicamatrix CRO Pvt Ltd, to manage contract research services in India.
 

FOR IMMEDIATE RELEASE

PRLog (Press Release)Oct 10, 2007 – Matrix Group (Hyderabad, India) and ethica Clinical Research (Montreal, Canada) have formed a joint venture, ethicamatrix CRO Pvt Ltd, to manage contract research services in India. It will initially focus on study monitoring, data management, and investigator training.

The new company will conduct clinical trials in India for life sciences companies in Europe and North America, allowing them to benefit from lower research costs and enhanced availability of trial subjects. ethica also expects to pick up business from Indian pharmaceutical companies requiring clinical trials in Canada.

Several teaching hospitals, including Shree Venkateswara Institute of Medical Sciences (SVIMS), are reported to be seeking partnerships with ethicamatrix. SVIMS, located in Tirupati, Andra Pradesh, is one of two teaching hospitals in the state to have received national status from the All India Institute of Medical Science (AIIMS).

Founded in 2002, ethica is the first Canadian CRO to establish a joint venture with a similar Indian firm. Established in 1996 by chairman and managing director Mr Siva Prasad, Matrix Group is active in the life sciences, aquaculture and agricultural sectors.

Ethica says it is the only CRO in the world to have earned full accreditation from the Association for the Accreditation of Human Research Protection Programs. It intends to seek AAHRPP accreditation for ethicamatrix in due course. “We intend to build ethicamatrix into the premiere self-regulated CRO in India,” said ethica director of clinical and scientific affairs Murray Jensen. Submitted by www.jobs4dd.com

# # #

www.jobs4dd.com is a specialist online recruitment service for the clinical trial and drug development sectors. Working in partnership with BioPharm Knowledge Publishing to provide latest industry news and jobs. Latest international clinical research jobs, CRM jobs, regulatory affairs jobs, pharmacovigilance vacancies, medical writing jobs and many more vacancies are listed on the www.jobs4dd.com website

# # # + Share This Article Click to see PDF Version of this Press Release

Email to a Friend   Email to Author       Previous News   Next News


Issued By:Jobs4 Drug Development Ltd
Website:http://www.jobs4dd.com
Email:Click to contact author
Phone:+44 1256 336632
Categories:Biotech
Tags:clinical research, clinicl trials, Cro, cra, Crm, drug development, pharma development, regulatory affairs jos

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases.   Report Abuse


Search Jobs / Post Jobs New

Related ......???

Serbian CRO becomes WCT’s fifth acquisition

Algorithme buys US research unit from BASi

Datatrak Closes German Office As Share Price Falls Below $1

Veeda Oncology acquires Biologie et Industrie, based in Paris

Veeda Oncology acquires French CRO


Most Viewed (Last 7 days)

Prescription Drug Addiction and Recovery, "The Night is Always Darkest Before the Dawn" - 1233 views

Maria Sharapova Wins ESPY Award 2008 - 1219 views

A Trusty Contact Lens Site With Free Price Comparing Service Of Brand Contact Lenses Gain Success! - 936 views

Hardgainer Fundamental Tips Every Natural Trainee Should Know About - 634 views

Why Spam Can’t Be Stopped – Emailappenders And Others Sell Bogus Lists - 446 views



Previous News

Next News

Are you a Journalist?


For Businesses ...


Tutorial on Free Marketing




How to Write a Press Release| SiteMap| Contact PRLog| Privacy Policy| Terms of Use| Copyright Notice